Endocrine disrupters as obesogens
Top Cited Papers
- 25 May 2009
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 304 (1-2), 19-29
- https://doi.org/10.1016/j.mce.2009.02.018
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)International Journal of Obesity, 2005
- Bisphenol A Accelerates Terminal Differentiation of 3T3-L1 Cells into Adipocytes through the Phosphatidylinositol 3-Kinase PathwayToxicological Sciences, 2005
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36The New England Journal of Medicine, 2003
- Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamatesBiochemical and Biophysical Research Communications, 2003
- Tributyltin or Triphenyltin Inhibits Aromatase Activity in the Human Granulosa-like Tumor Cell Line KGNBiochemical and Biophysical Research Communications, 2001
- Insulin Sensitizer, Troglitazone, Directly Inhibits Aromatase Activity in Human Ovarian Granulosa CellsBiochemical and Biophysical Research Communications, 2000
- The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 DiabetesBiochemical and Biophysical Research Communications, 2000
- Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte DifferentiationThe New England Journal of Medicine, 1998
- The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferatorToxicology and Applied Pharmacology, 1991